Bio-Rad launched its QX Continuum digital PCR system, utilizing Nuvia wPrime 2A resin and Foresight Pro columns.
1 report, 1 independent
Updated Jul 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Bio-Rad launched its QX Continuum digital PCR system, utilizing Nuvia wPrime 2A resin and Foresight Pro columns.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Continuum
user interface
Nothing else this week.
-
Bio-Rad Laboratories
American life science research firm
- Strategic acquisitions and product launches are driving growth for Bio-Rad Laboratories in the life science ddPCR and clinical diagnostics markets.
- Bio-Rad Laboratories is applying digital PCR technology through current partnerships, including Biodesix, Gencove, Insight Molecular, and Stilla Technologies.
-
Nuvia
American silicon design company
Nothing else this week.
Coverage
Newest first; wire copies grouped- Insider MonkeyBio-Rad Laboratories, Inc. (BIO) Launches New Digital PCR Systems in 2025 We recently compiled a list of 10 Most Undervalued Healthcare Stocks to Buy According to Analysts. Bio-Rad Laboratories, Inc.